KA
GILD icon

KLCM Advisors’s Gilead Sciences GILD Stock Holding History

KLCM Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Buy
1,730
+22
+1% +$2.9K 0.02% 271
2026
Q1 		$238K Hold
1,708
– – 0.02% 233
2025
Q4 		$210K Sell
1,708
-150
-8% -$18.2K 0.02% 233
2025
Q3 		$206K Buy
1,858
+50
+3% +$5.68K 0.02% 161
2025
Q2 		$200K Hold
1,808
– – 0.02% 163
2025
Q1 		$203K Buy
+1,808
New +$187K 0.02% 162
2024
Q3 		– Sell
-36,203
Closed -$2.48M – 169
2024
Q2 		$2.48M Buy
+36,203
New +$2.42M 0.31% 47
2022
Q4 		– Sell
-47,240
Closed -$2.91M – 130
2022
Q3 		$2.91M Buy
47,240
+1,802
+4% +$114K 0.68% 37
2022
Q2 		$2.81M Buy
+45,438
New +$2.81M 0.63% 38

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KLCM Advisors's GILD Position: Q2 2026 in Review

KLCM Advisors increased its Gilead Sciences (GILD) stake by 1.3% in Q2 2026, buying an estimated $2.9K and bringing the position to 1,730 shares worth $219K. The position accounts for 0.02% of the portfolio, ranked #271.

KLCM Advisors first reported a position in GILD in Q2 2022 and has held it in 9 quarters since. The position peaked at $2.91M in Q3 2022. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • KLCM Advisors held 1,730 shares of Gilead Sciences worth $219K as of Q2 2026.
  • KLCM Advisors bought 22 Gilead Sciences shares in Q2 2026, an estimated $2.9K.
  • Gilead Sciences made up 0.02% of KLCM Advisors's portfolio in Q2 2026, its #271 holding.
  • KLCM Advisors first reported a position in Gilead Sciences in Q2 2022 and has held it in 9 quarters since.
  • KLCM Advisors's Gilead Sciences position peaked at $2.91M in Q3 2022.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on KLCM Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.